Darren Alexander Rubin

US Patent:

D674895, Jan 22, 2013

Filed:

Jan 21, 2011

Appl. No.:

29/372851

Inventors:

Darren Rubin - Wesley Chapel FL, US

International Classification:

2402

US Classification:

D24129

US Patent:

20020073995, Jun 20, 2002

Filed:

Dec 18, 2000

Appl. No.:

09/740605

Inventors:

Darren Rubin - Land O' Lakes FL, US

International Classification:

A61M015/00

US Classification:

128/203140

Abstract:

A breathing support system comprises a housing, a plate with a central aperture forming an annular bearing surface and with peripheral air passageways and a cap with a base and a wall slidably extending into the distal region. Air ports have a tubular guide extending proximally from the base. A valve assembly includes a disc formed with a periphery selectively positionable in contact with the bearing surface and passageways and also includes a thin rod with a distal end adjustably received within the guide. A resilient member is positioned between the base and plate urging the base and cap distally and the disc into contact with the bearing surface and passageways. An exhaust valve adapted to allow the exhaling of air is located on an upper radial extent of an intermediate region of the housing. A primary port is adapted to receive and support a bottle of primary medication.

US Patent:

20130327323, Dec 12, 2013

Filed:

Aug 19, 2013

Appl. No.:

13/969847

Inventors:

DARREN RUBIN - Largo FL, US

International Classification:

A61M 11/02

US Classification:

12820018, 12820014

Abstract:

Novel nebulizers and methods are provided for a nebulizer including a dialable negative pressure threshold valve that actuates in response to different negative pressures corresponding to different negative pressure threshold settings of actuation of the valve to influence inhalation effort, aerosol entrainment, and aerosol delivery.

US Patent:

6718969, Apr 13, 2004

Filed:

May 28, 2002

Appl. No.:

10/156206

Inventors:

Darren Rubin - Land O Lakes FL 34639
Howard Rubin - Land O Lakes FL 34639

International Classification:

A61H 3100

US Classification:

12820014, 482 13

Abstract:

A medication dosage inhaler system with a main body having a round hollow cylindrical inward portion and a plurality of apertures and a round hollow cylindrical inward portion with a radially displaced round cylindrical hollow medication passageway, a T-shaped adaptor having a stepped gas connector forming an open pathway for the deliverance of a medical gas, an end cap having a one way valve for a one way flow of gas there through and a plurality of apertures, a medication dosage delivery container having a projecting medication delivering tube, a mouthpiece, and an oxygen source to mate with the stepped gas connector of the T-shaped adaptor.

US Patent:

20220331236, Oct 20, 2022

Filed:

Jun 23, 2022

Appl. No.:

17/847606

Inventors:

- Largo FL, US
Darren Rubin - Largo FL, US

International Classification:

A61K 9/00
A61J 7/00
A61K 31/137

Abstract:

The present invention provides methods of non-gastrointestinal transmucosal drug delivery that secures, sheaths, and protects vasoconstricting and or adrenergic drug from mixing with saliva and being swallowed, thereby preventing both decreased bioavailability and loss of efficacy, and ensuring restoration of proper blood perfusion. In preferred embodiments, the adrenergic drug is epinephrine and the method treats hypotension associated with anaphylaxis.

US Patent:

20210338601, Nov 4, 2021

Filed:

Jul 12, 2021

Appl. No.:

17/372753

Inventors:

- Largo FL, US
Darren Rubin - Largo FL, US

International Classification:

A61K 31/045
A61M 25/10

Abstract:

A liquid injectable pharmaceutical drug product consisting of no less that 99 percent ethanol comprised of no less than 99 percent ethanol active pharmaceutical ingredient with a volume of at least 0.05 mL to be injected into a patient as a method of ablating/lysing cells.

US Patent:

20200268656, Aug 27, 2020

Filed:

May 14, 2020

Appl. No.:

16/874455

Inventors:

Darren Rubin - Largo FL, US
Howard Rubin - Land O Lakes FL, US

International Classification:

A61K 9/00
A61K 31/045
A61K 9/08

Abstract:

Methods of the present disclosure utilize alcohol (e.g., ethanol) as an active ingredient or agent for disinfecting, washing, and/or treating infection in the upper and/or lower airways. Methods include aerosol inhalation, lung spraying, and/or lung lavage using ethanol-containing solutions. Such methods can be applied to complicated pneumonia and respiratory pandemics, including the COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

US Patent:

20200163904, May 28, 2020

Filed:

Mar 23, 2018

Appl. No.:

15/933631

Inventors:

DARREN RUBIN - LARGO FL, US

International Classification:

A61K 31/045
A61M 25/10

Abstract:

A liquid injectable pharmaceutical drug product consisting of no less than 99 percent ethanol comprised of no less than 99 percent ethanol active pharmaceutical ingredient with a volume of at least 0.05 mL to be injected into a patient as a method of ablating/lysing cells.